vs
Harmony Biosciences Holdings, Inc.（HRMY）与Revolve Group, Inc.（RVLV）财务数据对比。点击上方公司名可切换其他公司
Revolve Group, Inc.的季度营收约是Harmony Biosciences Holdings, Inc.的1.3倍（$324.4M vs $243.8M），Harmony Biosciences Holdings, Inc.净利率更高（9.2% vs 5.7%，领先3.5%），Harmony Biosciences Holdings, Inc.同比增速更快（21.1% vs 10.4%），Harmony Biosciences Holdings, Inc.自由现金流更多（$126.0M vs $-13.3M），过去两年Harmony Biosciences Holdings, Inc.的营收复合增速更高（25.6% vs 9.5%）
哈莫尼生物科学控股公司是一家处于商业化阶段的生物制药企业，专注于罕见神经及中枢神经系统疾病创新疗法的研发与商业化，核心产品针对发作性睡病等睡眠相关中枢神经系统病症，主要市场为美国。
Revolve Theatre Company是总部位于英国泰晤士河畔亨利的剧团，专注于创作演出政治题材和莎士比亚系列戏剧作品，由奥利弗·登奇、乔·莫里斯与汤姆·史密斯共同创立运营。
HRMY vs RVLV — 直观对比
营收规模更大
RVLV
是对方的1.3倍
$243.8M
营收增速更快
HRMY
高出10.7%
10.4%
净利率更高
HRMY
高出3.5%
5.7%
自由现金流更多
HRMY
多$139.3M
$-13.3M
两年增速更快
HRMY
近两年复合增速
9.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $243.8M | $324.4M |
| 净利润 | $22.5M | $18.6M |
| 毛利率 | 71.9% | 53.3% |
| 营业利润率 | 15.8% | 6.3% |
| 净利率 | 9.2% | 5.7% |
| 营收同比 | 21.1% | 10.4% |
| 净利润同比 | -54.6% | 50.4% |
| 每股收益（稀释后） | $0.38 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HRMYRVLV
| Q4 25 | $243.8M | $324.4M | ||
| Q3 25 | $239.5M | $295.6M | ||
| Q2 25 | $200.5M | $309.0M | ||
| Q1 25 | $184.7M | $296.7M | ||
| Q4 24 | $201.3M | $293.7M | ||
| Q3 24 | $186.0M | $283.1M | ||
| Q2 24 | $172.8M | $282.5M | ||
| Q1 24 | $154.6M | $270.6M |
净利润HRMYRVLV
| Q4 25 | $22.5M | $18.6M | ||
| Q3 25 | $50.9M | $21.2M | ||
| Q2 25 | $39.8M | $10.2M | ||
| Q1 25 | $45.6M | $11.8M | ||
| Q4 24 | $49.5M | $12.3M | ||
| Q3 24 | $46.1M | $11.0M | ||
| Q2 24 | $11.6M | $15.4M | ||
| Q1 24 | $38.3M | $10.9M |
毛利率HRMYRVLV
| Q4 25 | 71.9% | 53.3% | ||
| Q3 25 | 75.1% | 54.6% | ||
| Q2 25 | 81.0% | 54.1% | ||
| Q1 25 | 82.7% | 52.0% | ||
| Q4 24 | 73.0% | 52.5% | ||
| Q3 24 | 77.0% | 51.2% | ||
| Q2 24 | 81.4% | 54.0% | ||
| Q1 24 | 82.2% | 52.3% |
营业利润率HRMYRVLV
| Q4 25 | 15.8% | 6.3% | ||
| Q3 25 | 27.3% | 7.1% | ||
| Q2 25 | 24.0% | 5.8% | ||
| Q1 25 | 30.4% | 5.0% | ||
| Q4 24 | 27.7% | 3.9% | ||
| Q3 24 | 33.2% | 5.0% | ||
| Q2 24 | 12.4% | 5.8% | ||
| Q1 24 | 33.7% | 3.4% |
净利率HRMYRVLV
| Q4 25 | 9.2% | 5.7% | ||
| Q3 25 | 21.2% | 7.2% | ||
| Q2 25 | 19.8% | 3.3% | ||
| Q1 25 | 24.7% | 4.0% | ||
| Q4 24 | 24.6% | 4.2% | ||
| Q3 24 | 24.8% | 3.9% | ||
| Q2 24 | 6.7% | 5.4% | ||
| Q1 24 | 24.8% | 4.0% |
每股收益（稀释后）HRMYRVLV
| Q4 25 | $0.38 | $0.27 | ||
| Q3 25 | $0.87 | $0.29 | ||
| Q2 25 | $0.68 | $0.14 | ||
| Q1 25 | $0.78 | $0.16 | ||
| Q4 24 | $0.85 | $0.18 | ||
| Q3 24 | $0.79 | $0.15 | ||
| Q2 24 | $0.20 | $0.21 | ||
| Q1 24 | $0.67 | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $775.3M | $292.3M |
| 总债务越低越好 | $163.7M | — |
| 股东权益账面价值 | $870.2M | $512.5M |
| 总资产 | $1.3B | $765.0M |
| 负债/权益比越低杠杆越低 | 0.19× | — |
8季度趋势，按日历期对齐
现金及短期投资HRMYRVLV
| Q4 25 | $775.3M | $292.3M | ||
| Q3 25 | $672.6M | $315.4M | ||
| Q2 25 | $565.3M | $310.7M | ||
| Q1 25 | $507.0M | $300.8M | ||
| Q4 24 | $467.2M | $256.6M | ||
| Q3 24 | $410.5M | $252.8M | ||
| Q2 24 | $346.9M | $244.7M | ||
| Q1 24 | $372.4M | $273.4M |
总债务HRMYRVLV
| Q4 25 | $163.7M | — | ||
| Q3 25 | $168.5M | — | ||
| Q2 25 | $172.1M | — | ||
| Q1 25 | $175.7M | — | ||
| Q4 24 | $179.3M | — | ||
| Q3 24 | $182.8M | — | ||
| Q2 24 | $186.4M | — | ||
| Q1 24 | $190.0M | — |
股东权益HRMYRVLV
| Q4 25 | $870.2M | $512.5M | ||
| Q3 25 | $835.1M | $490.2M | ||
| Q2 25 | $773.1M | $468.6M | ||
| Q1 25 | $720.5M | $453.4M | ||
| Q4 24 | $659.2M | $437.8M | ||
| Q3 24 | $596.8M | $420.8M | ||
| Q2 24 | $538.6M | $405.8M | ||
| Q1 24 | $515.4M | $389.9M |
总资产HRMYRVLV
| Q4 25 | $1.3B | $765.0M | ||
| Q3 25 | $1.2B | $751.3M | ||
| Q2 25 | $1.1B | $722.9M | ||
| Q1 25 | $1.1B | $713.9M | ||
| Q4 24 | $999.2M | $665.5M | ||
| Q3 24 | $928.1M | $670.9M | ||
| Q2 24 | $858.4M | $657.8M | ||
| Q1 24 | $847.0M | $650.0M |
负债/权益比HRMYRVLV
| Q4 25 | 0.19× | — | ||
| Q3 25 | 0.20× | — | ||
| Q2 25 | 0.22× | — | ||
| Q1 25 | 0.24× | — | ||
| Q4 24 | 0.27× | — | ||
| Q3 24 | 0.31× | — | ||
| Q2 24 | 0.35× | — | ||
| Q1 24 | 0.37× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $126.2M | $-10.2M |
| 自由现金流经营现金流 - 资本支出 | $126.0M | $-13.3M |
| 自由现金流率自由现金流/营收 | 51.7% | -4.1% |
| 资本支出强度资本支出/营收 | 0.0% | 1.0% |
| 现金转化率经营现金流/净利润 | 5.61× | -0.55× |
| 过去12个月自由现金流最近4个季度 | $347.9M | $48.0M |
8季度趋势，按日历期对齐
经营现金流HRMYRVLV
| Q4 25 | $126.2M | $-10.2M | ||
| Q3 25 | $108.7M | $11.8M | ||
| Q2 25 | $79.3M | $12.6M | ||
| Q1 25 | $34.0M | $45.1M | ||
| Q4 24 | $75.6M | $3.9M | ||
| Q3 24 | $70.5M | $9.1M | ||
| Q2 24 | $42.6M | $-24.7M | ||
| Q1 24 | $31.1M | $38.4M |
自由现金流HRMYRVLV
| Q4 25 | $126.0M | $-13.3M | ||
| Q3 25 | $108.7M | $7.5M | ||
| Q2 25 | $79.3M | $10.4M | ||
| Q1 25 | $33.9M | $43.4M | ||
| Q4 24 | $75.0M | $2.1M | ||
| Q3 24 | $70.5M | $8.0M | ||
| Q2 24 | $42.0M | $-25.7M | ||
| Q1 24 | $31.1M | $36.7M |
自由现金流率HRMYRVLV
| Q4 25 | 51.7% | -4.1% | ||
| Q3 25 | 45.4% | 2.5% | ||
| Q2 25 | 39.6% | 3.4% | ||
| Q1 25 | 18.3% | 14.6% | ||
| Q4 24 | 37.3% | 0.7% | ||
| Q3 24 | 37.9% | 2.8% | ||
| Q2 24 | 24.3% | -9.1% | ||
| Q1 24 | 20.1% | 13.5% |
资本支出强度HRMYRVLV
| Q4 25 | 0.0% | 1.0% | ||
| Q3 25 | 0.0% | 1.5% | ||
| Q2 25 | 0.0% | 0.7% | ||
| Q1 25 | 0.1% | 0.6% | ||
| Q4 24 | 0.3% | 0.6% | ||
| Q3 24 | 0.0% | 0.4% | ||
| Q2 24 | 0.4% | 0.4% | ||
| Q1 24 | 0.0% | 0.6% |
现金转化率HRMYRVLV
| Q4 25 | 5.61× | -0.55× | ||
| Q3 25 | 2.14× | 0.56× | ||
| Q2 25 | 1.99× | 1.24× | ||
| Q1 25 | 0.75× | 3.82× | ||
| Q4 24 | 1.53× | 0.32× | ||
| Q3 24 | 1.53× | 0.83× | ||
| Q2 24 | 3.68× | -1.60× | ||
| Q1 24 | 0.81× | 3.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HRMY
暂无分部数据
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
